103 related articles for article (PubMed ID: 274856)
21. [Ovarian function under mini-dose oral contraception. Echographic morphology of the ovaries and hormonology].
Doyen J; Schaaps JP; Lambotte R
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(3):317-25. PubMed ID: 3110257
[TBL] [Abstract][Full Text] [Related]
22. Contraception today and tomorrow.
Balmer JA
Acta Eur Fertil; 1975 Jun; 6(2):93-9. PubMed ID: 1103545
[No Abstract] [Full Text] [Related]
23. [Gonadotropic function during its use and after its cessation of a triphasic combination of gestodene].
Levaillant JM; Levaillant C; Colin MC; Rotten D
Rev Fr Gynecol Obstet; 1988 Oct; 83(10):655-61. PubMed ID: 3144031
[TBL] [Abstract][Full Text] [Related]
24. [Clinical pharmacology of hormonal contraceptives].
Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
[No Abstract] [Full Text] [Related]
25. [Clinical and metabolic effects of oral contraceptives].
Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
[TBL] [Abstract][Full Text] [Related]
26. The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound.
Skouby SO
Contraception; 1976 Nov; 14(5):529-39. PubMed ID: 989747
[No Abstract] [Full Text] [Related]
27. The effect of ampicillin on oral contraceptive effectiveness.
Friedman CI; Huneke AL; Kim MH; Powell J
Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714
[TBL] [Abstract][Full Text] [Related]
28. [Control of gonadotropin secretion in man].
Franchimont P
Rev Clin Esp; 1970 Dec; 119(6):491-500. PubMed ID: 4928317
[No Abstract] [Full Text] [Related]
29. [Gonadotropin secretion in man].
Franchimont P
Munch Med Wochenschr; 1970 Dec; 112(51):2303-12. PubMed ID: 5537017
[No Abstract] [Full Text] [Related]
30. [The effect of different types of oral contraceptives upon ovarian function (author's transl)].
Aktories K; Krög W; Dericks-Tan JS; Jürgensen O; Taubert HD
Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):318-26. PubMed ID: 1269893
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic studies with a new progestational substance -- ORG 2969 -- in combination with ethinyloestradiol.
Alapiessa U; Assendorp R; Hirvonen E; Hulkko S; Järvi K; Korhonen M; Käär K; Lauslahti K; Liukko P; Lumiala I; Pora O; Punnonen R; Rhen K; Ruokonen A; Saranen M; Tarkkila T; Viinikka L; Virkkunen P; Weijers M; Widholm O
Acta Obstet Gynecol Scand Suppl; 1979; 85():1-21. PubMed ID: 377898
[No Abstract] [Full Text] [Related]
32. [Central effects of the depot gestagens norgestrel capronate and norgestrel undecylate and their usefulness as long-term contraceptives].
Geiger W
Arch Gynakol; 1975 Nov; 219(1-4):604-6. PubMed ID: 1243506
[No Abstract] [Full Text] [Related]
33. The place of combined oral contraceptives in contraception.
MacGregor EA; de Lignières B
Cephalalgia; 2000 Apr; 20(3):157-63. PubMed ID: 10997768
[No Abstract] [Full Text] [Related]
34. Levels of serum follicle-stimulating hormone, luteinizing hormone, and plasma progestin during microdose chlormadinone treatment.
Taymor ML; Levesque LA
Fertil Steril; 1971 Jan; 22(1):1-8. PubMed ID: 4099041
[No Abstract] [Full Text] [Related]
35. Desogestrel-only pill (Cerazette).
Faculty of Family Planning & Reproductive Health Care, Clinical Effectiveness Unit
J Fam Plann Reprod Health Care; 2003 Jul; 29(3):162-4. PubMed ID: 12885316
[No Abstract] [Full Text] [Related]
36. Letter: Changing from a high- to low-dose oral contraceptive.
Briggs M
Br Med J; 1975 Mar; 1(5957):575. PubMed ID: 1139163
[No Abstract] [Full Text] [Related]
37. Effect of oral (combination and progestogen alone) and injectable contraceptives on serum copper levels.
Donde UM; Virkar K
Indian J Med Res; 1976 Jun; 64(6):787-91. PubMed ID: 977035
[No Abstract] [Full Text] [Related]
38. Reversal of pentobarbital blockade of ovulation after cardiac puncture.
Proudfit CM; Schwartz NB
Endocrinology; 1974 Feb; 94(2):526-31. PubMed ID: 4810386
[No Abstract] [Full Text] [Related]
39. [Hormonal properties of new 17 alpha-hydroxyprogesterone derivatives].
Nikitina GV; Savchenko ON; Stepanov MG
Probl Endokrinol (Mosk); 1987; 33(3):60-3. PubMed ID: 3116530
[TBL] [Abstract][Full Text] [Related]
40. [New gestagens--advantages and disadvantages].
Kuhl H
Ther Umsch; 2001 Sep; 58(9):527-33. PubMed ID: 11594150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
